Dark Forest Capital Management LP Cytokinetics Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$63.75 - $108.06 $920,358 - $1.56 Million
14,437 New
14,437 $1.01 Million
Q2 2023

Aug 14, 2023
BUY
$32.62 - $40.75 $476,871 - $595,724
14,619 Added 211.04%
21,546 $702,000
Q1 2023

May 12, 2023
BUY
$33.36 - $45.71 $231,084 - $316,633
6,927 New
6,927 $243,000
Q4 2021

Feb 11, 2022
SELL
$34.35 - $46.38 $6,629 - $8,951
-193 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$18.54 - $35.74 $296 - $571
-16 Reduced 7.66%
193 $7,000
Q2 2021

Aug 16, 2021
BUY
$19.79 - $26.99 $4,136 - $5,640
209 New
209 $4,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email